| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/27/2013 | CN102942705A Micro-patterned temperature-sensitive chitosan membrane and preparation method thereof |
| 02/27/2013 | CN102942660A Natural biological crosslinking nanocomposite three-dimensional gel bracket and preparation method |
| 02/27/2013 | CN102942631A Humanized anti-cmet antagonists |
| 02/27/2013 | CN102942623A AtTAR2 protein and application of AtTAR2 protein coding genes to regulation of plant lateral root growth |
| 02/27/2013 | CN102942621A Plant powdery mildew resistance related protein TaCAF1 and its coding gene and application |
| 02/27/2013 | CN102942618A Telomeric protein polypeptide fragment with tumor cell killing activity and application thereof |
| 02/27/2013 | CN102942616A Peptide capable of binding to immunoglobulin |
| 02/27/2013 | CN102940880A Growth factor complex |
| 02/27/2013 | CN102940631A Application of Blebbistatin in promoting stem cell survival and keeping stem cell dry |
| 02/27/2013 | CN102382793B Method for extracting cotton mitochondria and ribose nucleic acid (RNA) of cotton mitochondria |
| 02/27/2013 | CN102352357B dsRNA (ribonucleic acid) capable of inhibiting FLPs neuropeptide gene and application thereof |
| 02/27/2013 | CN102329776B PK-15 cell line for expressing Nectin-1 gene extracellular region segment and building method thereof |
| 02/27/2013 | CN102219839B Gene SRL-1 for controlling leaf shape of paddy rice and application thereof |
| 02/27/2013 | CN102206641B Promoter SbUbi1, its preparation method and use |
| 02/27/2013 | CN102181410B Method for producing laccase by virtue of fermentation |
| 02/27/2013 | CN102146403B Promoter BgIosP 596, and preparation method and application thereof |
| 02/27/2013 | CN102146400B BgIosP585 promoter, preparation method and application |
| 02/27/2013 | CN102146395B Promoter BgIosP545 as well as preparation method and application thereof |
| 02/27/2013 | CN102146393B BGIosP515 promoter and application of BGIosP515 promoter |
| 02/27/2013 | CN102146391B Promoter BgIosP 520, preparation method and application thereof |
| 02/27/2013 | CN102146390B BgIosP517 promoter, preparation method and application of BgIosP517 promoter |
| 02/27/2013 | CN102146389B BgIosP580 promoter, preparation method and application |
| 02/27/2013 | CN102146388B BgIosP569 promoter, preparation method and application |
| 02/27/2013 | CN102094016B BGIos405 gene and application thereof |
| 02/27/2013 | CN102094014B BGIos1003 gene and application thereof |
| 02/27/2013 | CN102094013B BGIos1005 gene and application thereof |
| 02/27/2013 | CN102080088B Cotton dehydrin similar gene and application thereof |
| 02/27/2013 | CN102079788B Method for detecting sulfanilamide medicine and special enzyme-linked immunoassay reagent kit thereof |
| 02/27/2013 | CN102010469B Hyaluronic acid resistance monoclonal antibody and application thereof |
| 02/27/2013 | CN102002497B Molecular mark SIsv0115 tightly interlinked with millet plant height gene |
| 02/27/2013 | CN101979545B Nucleotide sequence and vector for directional cloning |
| 02/27/2013 | CN101948518B Method for preparing functional protein RJCPs by royal jelly and application |
| 02/27/2013 | CN101921336B Monoclonal antibody against human alpha1 acid glycoprotein and preparation method thereof |
| 02/27/2013 | CN101712946B Method for structuring model for culturing genital tubercle organ for urethra ectogenesis |
| 02/27/2013 | CN101355959B Black bear parathyroid hormone and methods of using black bear parathyroid hormone |
| 02/26/2013 | US8383915 Maize variety hybrid X8F926 |
| 02/26/2013 | US8383914 Maize variety hybrid X8H569 |
| 02/26/2013 | US8383907 Maize variety hybrid X03A184 |
| 02/26/2013 | US8383902 Plants and seeds of hybrid corn variety CH999541 |
| 02/26/2013 | US8383894 Soybean variety A1023199 |
| 02/26/2013 | US8383893 Soybean variety A1020078 |
| 02/26/2013 | US8383886 Genes encoding a novel type of lysophophatidylcholine acyltransferases and their use to increase triacylglycerol production and/or modify fatty acid composition |
| 02/26/2013 | US8383802 Nucleic acids encoding antibodies that bind factor D |
| 02/26/2013 | US8383801 Polynucleotide encoding a sclerostin-binding antibody |
| 02/26/2013 | US8383800 MK167 mini-promoters |
| 02/26/2013 | US8383799 Translocation and mutant ROS kinase in human non-small cell lung carcinoma |
| 02/26/2013 | US8383788 For therapy of cancer or tumorous growth |
| 02/26/2013 | US8383782 Composite materials comprising supported porous gels |
| 02/26/2013 | US8383781 Anti-NIK antibodies and uses thereof |
| 02/26/2013 | US8383774 Collectin fusion proteins comprising TNF or trail |
| 02/26/2013 | US8383604 Modulation of BCL11A for treatment of hemoglobinopathies |
| 02/26/2013 | US8383601 Tissue specific gene therapy treatment |
| 02/26/2013 | US8383599 Methods and compositions for RNA interference |
| 02/26/2013 | US8383409 Cell culture substrate and its production method |
| 02/26/2013 | US8383408 Nanofibrillar structure and applications including cell and tissue culture |
| 02/26/2013 | US8383407 Percutaneous access device system facilitating cell growth thereon |
| 02/26/2013 | US8383406 Method for stimulating the proliferation of differentiated cells belonging to the chondrogenic lineage |
| 02/26/2013 | US8383405 Methods of using ideotypically modulated pharmacoeffectors for selective cell treatment |
| 02/26/2013 | US8383404 Hematopoietic stem cell identification and isolation |
| 02/26/2013 | US8383403 Reticulocyte mimetics and method of preparation of the same |
| 02/26/2013 | US8383402 Trichoplusia ni cell line and methods of use |
| 02/26/2013 | US8383401 T-cell receptor and nucleic acid encoding the receptor |
| 02/26/2013 | US8383399 Nucleic acid construct having an ovalbumin promotor |
| 02/26/2013 | US8383388 for oral administration; exhibit increased protein stability; exhibit increased stability in the bloodstream, following oral administration, and/or under storage conditions |
| 02/26/2013 | US8383359 Use of lymphocytes to measure anthrax lethal toxin activity |
| 02/26/2013 | US8383126 Bacterial pheromones and uses thereof |
| 02/26/2013 | US8383102 Fusion of peptidoglycan hydrolase enzymes to a protein transduction domain allows eradication of both extracellular and intracellular gram positive pathogens |
| 02/26/2013 | US8383098 Multipotent neural stem cells |
| 02/26/2013 | US8383095 Methods and compositions for enhancing engraftment of hematopoietic stem cells |
| 02/26/2013 | CA2674885C Anti-ige vaccines |
| 02/26/2013 | CA2674837C Anti-ige vaccines |
| 02/26/2013 | CA2633345C A method of affinity separation and ligands for use therein |
| 02/26/2013 | CA2600882C Chemically inducible expression of biosynthetic pathways |
| 02/26/2013 | CA2542035C Process for producing antithrombin iii composition |
| 02/26/2013 | CA2493822C Methods and compositions for targeting secretory lysosomes |
| 02/26/2013 | CA2493406C Gm-negative ehv-mutants without heterologous elements |
| 02/26/2013 | CA2440775C The nk1 fragment of hepatocyte growth factor/scatter factor (hgf/sf) and variants thereof, and their use |
| 02/26/2013 | CA2389644C A novel polypeptide hormone phosphatonin |
| 02/26/2013 | CA2369844C Nucleic acid sequences to proteins involved in tocopherol synthesis |
| 02/26/2013 | CA2350335C Host cells expressing recombinant human erythropoietin |
| 02/26/2013 | CA2342115C Nucleic acid molecules encoding enzymes having fructosyltransferase activity, and their use |
| 02/26/2013 | CA2327586C Fap.alpha.-specific antibody with improved producibility |
| 02/26/2013 | CA2324648C Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics, high throughput screening and novelty items |
| 02/26/2013 | CA2324381C An integrin heterodimer and a subunit thereof |
| 02/21/2013 | WO2013025963A2 Conversion of somatic cells into functional spinal motor neurons, and methods and uses thereof |
| 02/21/2013 | WO2013025763A2 Tissue engineering using injectable, oxidized alginate hydrogels |
| 02/21/2013 | WO2013025543A1 Cell chips |
| 02/21/2013 | WO2013025485A1 Transcription terminators |
| 02/21/2013 | WO2013025467A2 Methods of treating hematological proliferative disorders by targeting epha3 expressed on aberrant vasculature in bone marrow |
| 02/21/2013 | WO2013025461A1 Compositions and methods for inducing apoptosis |
| 02/21/2013 | WO2013025189A1 Methods for co-culturing cord blood cells or cord tissue cells with menstrual multipotent cells |
| 02/21/2013 | WO2013024867A1 Antibody and use thereof |
| 02/21/2013 | WO2013024817A1 Two-dimensional cell spreading device and cell spreading method using same |
| 02/21/2013 | WO2013024527A1 Method for producing alkane and recombinant microorganism having alkane-synthesizing ability |
| 02/21/2013 | WO2013024410A1 Method for in-vitro treatment of differentiated or undifferentiated cells by application electromagnetic fields |
| 02/21/2013 | WO2013024096A1 In vitro modelling of haematopoietic stem cell medullary nests: a tool for studying the regulation of haematopoiesis, evaluating the nesting potential of a haematopoietic graft and testing the pharmacotoxicology of medicaments |
| 02/21/2013 | WO2013024024A2 Quality assessment of induced pluripotent cells by referring to splicing signatures of pluripotency |
| 02/21/2013 | WO2013023557A1 Humanized monoclone antibody of macrophage inhibition factor 1 and use thereof |
| 02/21/2013 | WO2013023361A1 Uses of human zfx gene and related drugs thereof |
| 02/21/2013 | WO2013023319A1 In vitro method for modifying the depletion profile of treg cells present in a total splenocyte population of a biological sample by means of the isolation, culturing and exposure thereof to an atp and polymixin b medium |